SUNNYVALE, Calif., Feb. 19, 2021 /PRNewswire/ -- Accuray
Incorporated (NASDAQ: ARAY) announced today the appointment of
Byron C. Scott, M.D., MBA to the
company's Board of Directors, effective as of February 12, 2021. Dr. Scott brings significant
experience as a physician executive with invaluable global
expertise in healthcare analytics and technology.
Dr. Scott is currently on the faculties at the University of Massachusetts, Amherst, Isenberg School of Management and Jefferson
University, College of Population Health where he teaches
healthcare quality, patient safety, and performance improvement.
Previously, Dr. Scott served as Deputy Chief Health Officer at IBM
Watson Health, where he successfully guided healthcare
organizations in the alignment of strategies, quality and
performance improvement, and was an industry-recognized thought
leader with respect to Watson Health products and services. Dr.
Scott also held leadership roles at Truven Health Analytics, a
company providing healthcare quality and efficiency solutions using
data, analytics, and consulting, prior to its acquisition by IBM.
Previous to his tenure at Truven, Dr. Scott held positions of
increasing responsibility at EmCare, a hospital-based physician
practice management company that was part of Envision Healthcare,
including most recently, as Executive Vice President of the West
Division.
"We are pleased to welcome Dr. Scott to the Accuray Board and
look forward to working with him during this exciting time in the
company's evolution. Accuray continues to develop and introduce
differentiated solutions to meet the needs of a continually
changing radiation therapy market. Dr. Scott's background as a
physician and expertise in healthcare technology will enable him to
offer a unique and important perspective to our management team,"
said Joshua H. Levine, President and
Chief Executive Officer.
"During my tenure in the healthcare technology arena, I've had
the opportunity to work with many senior management teams to
successfully accelerate their organization's growth. I joined the
Accuray Board because I believe my experience will give me the
insights necessary to make a meaningful contribution to the
achievement of the company's financial goals. I truly believe in
the organization's vision and the potential of its industry-leading
radiation therapy solutions," said Byron C.
Scott, M.D., MBA.
About Accuray
Accuray is committed to expanding the powerful potential of
radiation therapy to improve as many lives as possible. We invent
unique, market-changing solutions that are designed to deliver
radiation treatments for even the most complex cases—while making
commonly treatable cases even easier—to meet the full spectrum of
patient needs. We are dedicated to continuous innovation in
radiation therapy for oncology, neuro-radiosurgery, and beyond, as
we partner with clinicians and administrators, empowering them to
help patients get back to their lives, faster. Accuray is
headquartered in Sunnyvale,
California, with facilities worldwide. To learn more, visit
www.accuray.com or follow us on Facebook, LinkedIn, Twitter,
and YouTube.
Media Contact:
Beth
Kaplan
Accuray
+1 (408)
789-4426
bkaplan@accuray.com
Investor Contact
Joe Diaz
Investor Relations - Accuray
Tel: +1 (602) 717-7804
E-mail: jdiaz@accuray.com
View original content to download
multimedia:http://www.prnewswire.com/news-releases/accuray-appoints-healthcare-executive-and-physician-byron-c-scott-to-board-of-directors-301231609.html
SOURCE Accuray Incorporated